The Res-Q™ BMC system processes autologous bone marrow concentrate effectively and safely at point-of-care in less than 15 minutes.
Efficiency: The patented system maximizes the % yield of mononucleated cells at the point-of-care while reducing sample volume by up to 20X .
Safety: The system decreases the potential for tissue contamination by utilizing a closed system design providing a clear pathway between patient and centrifuge. |
